5-Min Science: When Your Immune System Hijacks Your Mind

This post draws from recent peer-reviewed research and Rachel Aviv's compelling New Yorker investigation "Mary Had Schizophrenia—Then Suddenly She Didn't" (July 2025), which chronicles extraordinary cases of psychiatric recovery through immune system treatments.

Picture this: You're sitting in a college lecture hall, trying to focus on your professor's words, but the voices in your head are getting louder. Your thoughts feel scattered like puzzle pieces that won't fit together. For decades, scientists believed this nightmare scenario, schizophrenia, was purely a "chemical imbalance" in the brain. But what if we've been looking in the wrong place? What if the real culprit has been hiding in plain sight, disguised as your body's own defense system?

A groundbreaking story is emerging from psychiatric research labs across the globe, and it's turning everything we thought we knew about schizophrenia upside down. The twist? Your immune system, the same biological army that fights off infections and heals wounds, might actually be the villain in this story, launching a misguided attack on your own brain.

The Case of Mary: When Cancer Treatment Cured Madness

To understand this revolution, let's start with an extraordinary case that reads like medical science fiction. Mary, a 55-year-old former physician, had lived with severe schizophrenia for over two decades. She believed professors from her medical school were sending her secret messages, convinced her daughters were spies, and barricaded herself behind furniture to escape imaginary threats. Her world was a prison of paranoia and delusion.

Then came an unexpected plot twist: Mary was diagnosed with lymphoma, a form of blood cancer. As part of her cancer treatment, doctors gave her rituximab, a powerful drug that suppresses the immune system. Something remarkable happened. As the chemotherapy attacked her cancer, it also began dismantling her psychosis. After 20 years of mental illness, Mary's delusions simply... vanished.

Her daughter Christine described it as watching her mother become a "psychological debutante", emerging into sanity like someone stepping into society for the first time. Mary could suddenly watch the news without believing people were stealing her ideas. She asked for a phone, something she'd avoided for years because she thought it contained spyware. Most shocking of all, she had no memory of her delusions, as if they belonged to a completely different person.

The Immune System's Civil War

Mary's story isn't unique. Across medical centers worldwide, researchers are documenting similar cases where immune-suppressing treatments accidentally cure psychiatric symptoms. But how could this be possible?

Think of your immune system as an incredibly sophisticated military operation. Normally, this biological army protects you by identifying foreign invaders, viruses, bacteria, and toxins and launching precise strikes to eliminate them. But sometimes, this system goes rogue. Instead of protecting you, it turns its weapons on your own body, including your brain.

Recent studies reveal that in some people with schizophrenia, the immune system produces antibodies that attack crucial brain proteins.

Dr. Josep Dalmau at the University of Barcelona first discovered this phenomenon in 2007 when he identified anti-NMDA receptor encephalitis. Patients with this condition initially appeared to have schizophrenia, but when treated with immune-suppressing drugs instead of traditional antipsychotics, many recovered completely, sometimes within weeks.

The Pregnancy Connection: How Inflammation Rewires the Developing Brain

The immune-schizophrenia connection runs even deeper than adult autoimmune attacks. Scientists have discovered that inflammation during pregnancy can fundamentally alter how a developing baby's brain forms, potentially setting the stage for schizophrenia decades later.

Here's how it works: When a pregnant woman experiences severe infections, autoimmune flares, or chronic stress, her immune system releases inflammatory molecules called cytokines. These chemical messengers are supposed to fight threats, but they can cross into the developing fetus and interfere with crucial brain-building processes.

Specifically, these inflammatory signals can disrupt the development of GABAergic interneurons, specialized brain cells that act like the brain's internal brake system.

This discovery helps explain why schizophrenia often emerges in early adulthood, despite having roots in prenatal development. The brain circuits damaged by early inflammation might function adequately during childhood but fail under the increased demands of adult cognition and stress.

Microglia: The Brain's Overzealous Security Guards

Inside your brain right now, microscopic cells called microglia are patrolling like security guards, looking for signs of trouble. These cells are part of your brain's immune system, and normally they do essential maintenance work: clearing out cellular debris, supporting healthy neurons, and responding to injuries.

But in some people with schizophrenia, these microglia seem to be stuck in permanent "high alert" mode. Instead of performing routine maintenance, they're constantly releasing inflammatory chemicals and attacking healthy brain tissue. It's like having security guards who've become so paranoid that they start treating every visitor as a potential threat.

Neutrophils: Unlikely Villains in Mental Illness

While researchers have focused on the brain's immune cells, they've overlooked a surprising player in schizophrenia: neutrophils. These cells are your body's first responders to infection, typically found circulating in your bloodstream rather than in your brain.

Recent studies show that people with schizophrenia often have elevated levels of neutrophils and high neutrophil-to-lymphocyte ratios (NLR). Higher neutrophil counts correlate with more severe psychotic symptoms and greater cognitive impairment. This suggests that whole-body inflammation, not just brain inflammation, might contribute to psychiatric symptoms (Chen et al., 2025).

Think of it this way: if your entire immune system is in a state of chronic low-grade warfare, it's constantly sending inflammatory signals throughout your body, including to your brain. This persistent inflammatory background noise might gradually erode mental clarity and emotional stability over time.

Why Your Brain Stops Wanting Things: Inflammation and Motivation

One of the most devastating aspects of schizophrenia isn't the hallucinations or delusions, it's the profound loss of motivation and pleasure, known as negative symptoms. People with schizophrenia often lose interest in activities they once enjoyed, struggle to form social connections, and seem emotionally flat or withdrawn.

For years, these symptoms were considered the most mysterious and untreatable aspects of the condition. But groundbreaking research from Emory University has revealed a shocking connection: inflammation directly attacks the brain's reward and motivation circuits.

This finding is revolutionary because it suggests that anti-inflammatory treatments might restore motivation in ways that traditional antipsychotic medications cannot. Drugs like infliximab, originally developed for arthritis and inflammatory bowel disease, are now being tested as precision treatments for the motivational symptoms of schizophrenia.

The Autoimmune Masquerade: When Schizophrenia Isn't Really Schizophrenia

Perhaps the most mind-bending aspect of this research is the realization that some cases of "schizophrenia" might not be schizophrenia at all. They might be autoimmune conditions wearing a psychiatric disguise.

Dr. Sander Markx at Columbia University describes encountering a patient named April, who had been institutionalized for 20 years with what appeared to be chronic, treatment-resistant schizophrenia. When doctors finally tested her for autoimmune antibodies, they discovered she had lupus, an autoimmune disease that was causing brain inflammation and psychiatric symptoms.

After treatment with immunosuppressive therapy, including rituximab, April emerged from what Markx described as "essentially a 25-year-long coma." She could suddenly tell doctors everything about her experience, remember details from decades past, and function normally. As Markx put it: "We don't have a script for this. We don't see patients coming back from this condition."

The Search for Hidden Patients

This realization has sparked an urgent scientific mission: finding the patients with autoimmune psychosis who are currently misdiagnosed and undertreated. The Stavros Niarchos Foundation Center for Precision Psychiatry at Columbia University is now embarking on an ambitious project to screen every patient in New York State's psychiatric hospital system for autoimmune, metabolic, and genetic disorders.

The goal is to identify people whose symptoms can be traced to specific biological mechanisms rather than the broad, mysterious category of "schizophrenia." Dr. Joshua Gordon, executive director of the New York State Psychiatric Institute, explains: "If we identify a few dozen patients who can be treated effectively enough to leave the hospital, we will be able to start answering the question of whether this is worth trying across the whole population of people with schizophrenia."

The Treatment Revolution: From Antipsychotics to Immune Modulators

This immune-inflammation revolution is already changing how doctors think about treating schizophrenia. Traditional antipsychotic medications work by blocking dopamine receptors in the brain, which can reduce hallucinations and delusions but often fail to address negative symptoms and cognitive problems.

Now, researchers are testing a new arsenal of treatments borrowed from other medical specialties:

• Rituximab and other immune-suppressing drugs originally developed for cancer and autoimmune diseases

• Anti-TNF therapies like infliximab, used for rheumatoid arthritis and Crohn's disease

• Plasmapheresis, a procedure that filters harmful antibodies from the blood

• Immunoglobulins that can modulate immune system activity

These treatments target the underlying immune dysfunction rather than just managing symptoms. For patients with autoimmune psychosis, the results can be dramatic and swift, sometimes producing recoveries within weeks or months rather than years.

The Diagnostic Dilemma: Rethinking Mental Illness

This research is forcing psychiatry to confront an uncomfortable truth: the way we currently diagnose and categorize mental illness might be fundamentally flawed. The Diagnostic and Statistical Manual of Mental Disorders (DSM), psychiatry's diagnostic bible, groups conditions based on observable symptoms rather than underlying biological causes.

But what if "schizophrenia" isn't really a single disease at all? What if it's more like "fever", a symptom that can result from dozens of different underlying conditions, each requiring different treatments?

Dr. Christopher Bartley at the National Institute of Mental Health argues for "epistemic humility," accepting that there are alternative models of psychiatric disease that we're only beginning to understand. The immune-inflammation research suggests we need to develop more sophisticated diagnostic tools that can identify biologically distinct subtypes of psychosis.

The Broader Implications: Rewriting the Textbook of Mental Health

This inflammatory revolution extends far beyond schizophrenia. Researchers are finding immune-inflammation connections in depression, bipolar disorder, autism spectrum disorders, and even ADHD. The emerging picture suggests that psychiatric conditions exist on a spectrum of immune dysfunction, with different people having different degrees and types of inflammatory involvement.

This has profound implications for how we think about mental health stigma, treatment access, and research funding. If psychiatric symptoms can result from treatable medical conditions, it reinforces that mental illness is "real" medicine, not a character flaw or weakness.

It also highlights the artificial division between psychiatry and the rest of medicine. As Dr. Thomas Pollak at King's College London notes, psychiatry and neurology are "the only two fields of medicine that focus on the same organ," but use different diagnostic frameworks and treatments.

The Mystery of Memory: Why Some Patients Forget Their Illness

One of the most puzzling aspects of cases like Mary's is the profound amnesia that often accompanies recovery. People who emerge from autoimmune psychosis frequently have little or no memory of their delusional experiences, as if those years belonged to someone else entirely.

This phenomenon offers fascinating insights into the nature of memory and identity. The psychiatrist Eugen Bleuler described how people with schizophrenia can engage in "double bookkeeping", simultaneously living in both reality and delusion. When the inflammatory fog lifts, patients seem to access only the "reality" side of their memories, while the delusional experiences fade or become incomprehensible.

Dr. Steven Kushner, who evaluated Mary, believes this memory gap reflects a fundamental challenge to identity: "To look back and say, basically, 'Twenty years of my life were out of reality', that would be a fundamental blow to her identity as a physician and mom."

The Family Perspective: Loving Someone Through Madness and Recovery

The immune-inflammation research also sheds new light on the experiences of families affected by schizophrenia. Mary's daughters, Christine and Angie, spent decades trying to understand their mother's transformation and advocate for her care.

Christine became an expert in psychiatric diagnosis by high school, texting friends that she had "married the DSM-IV" and describing her mother's condition with clinical precision. But even with all her knowledge, she couldn't help her mother until the autoimmune connection was discovered.

The emergence from psychosis creates its own challenges. As Christine puts it: "When a person recovers from an illness, it is usually seen as the end of the story. But becoming sane also causes a kind of narrative collapse, a confrontation with a personal history that is no longer recognizable."

Families must navigate the complex emotions of grief, joy, and uncertainty. How do you rebuild relationships with someone who has no memory of the pain they caused? How do you trust that the recovery is permanent? These questions highlight the need for better support systems for families dealing with psychiatric illness and recovery.

The Future: Personalized Medicine for Mental Health

The immune-inflammation research points toward a future of truly personalized psychiatric medicine. Instead of treating all cases of "schizophrenia" with the same broad-spectrum medications, doctors could identify specific biological subtypes and target treatments accordingly.

For patients with autoimmune psychosis, immune-suppressing treatments might offer cures rather than just symptom management. For those with inflammatory signatures, anti-inflammatory drugs could prevent progression or reduce severity. For patients without immune involvement, traditional approaches might remain most appropriate.

This precision medicine approach could dramatically improve outcomes while reducing side effects and healthcare costs. It also offers hope to families who have watched loved ones struggle with treatment-resistant symptoms.

The Bigger Picture: What This Means for Understanding the Mind

Perhaps most profoundly, this research is changing our fundamental understanding of the relationship between body and mind. The discovery that immune dysfunction can so completely alter consciousness, personality, and perception demonstrates the deep biological roots of mental experience.

This has philosophical implications that extend beyond medicine. Suppose our thoughts, emotions, and sense of reality can be chemically hijacked by an immune system malfunction. What does that tell us about free will, personal responsibility, and the nature of the self?

At the same time, these findings offer tremendous hope. They suggest that some of the most devastating psychiatric conditions might be preventable or even curable with the right biological interventions. The immune system, for all its complexity, is more easily targeted with drugs than the mysterious processes of consciousness itself.

Key Takeaways

1. Prenatal Immune Activation Can Shape Brain Rhythms: Inflammatory cytokines may impair interneuron development during pregnancy, setting the stage for schizophrenia.

2. Microglia's Overdrive Disrupts Neural Support Systems: Chronic microglial activation impairs glial function and distorts neural network integrity.
   

3. Neutrophils Mirror Psychotic Severity: Elevated neutrophil levels and NLR correlate with worsening cognitive and psychotic symptoms.

   
   

4. Motivation May Be Undermined by Inflammation in Reward Circuits: Inflammatory activity may dull brain pathways essential for motivation, suggesting novel treatment avenues.

   
   

5. Schizophrenia May Be Many Diseases in Disguise: These findings underscore the need for subtype‑specific diagnosis, especially those with an inflammatory profile, toward more effective, individualized treatments.

Summary

The immune-inflammation revolution in psychiatry represents one of the most exciting developments in mental health research in decades. It offers hope for better treatments, deeper understanding, and ultimately, the possibility that some of our most challenging psychiatric conditions might not be lifelong sentences after all. For millions of people and families affected by mental illness, this research represents something precious: the promise of real recovery, not just management of symptoms.

As we continue to unravel the complex connections between immunity and mental health, we're not just discovering new treatments; we're fundamentally rewriting our understanding of what it means to be human, conscious, and mentally well. The revolution is just beginning.

Glossary

anti-NMDA receptor encephalitis: an autoimmune condition where antibodies attack NMDA receptors in the brain, causing psychiatric symptoms that can mimic schizophrenia but are potentially curable with immunotherapy.

antibodies: proteins produced by the immune system to identify and neutralize foreign substances, but which can sometimes mistakenly attack the body's own tissues.

antipsychotics: medications that treat psychotic symptoms like hallucinations and delusions by blocking dopamine receptors in the brain.

astrocytes: star-shaped brain cells that provide structural and nutritional support to neurons and help maintain the blood-brain barrier.

autoimmune condition: a disorder in which the immune system mistakenly attacks the body's own healthy tissues and organs.

cytokines: small proteins released by immune cells that act as chemical messengers to coordinate immune responses and inflammation.

delusions: fixed false beliefs that are resistant to reasoning or contrary evidence, often involving paranoia or grandiosity.

dopamine receptors: protein structures in the brain that bind to the neurotransmitter dopamine, playing crucial roles in movement, motivation, and reward processing.

DSM (Diagnostic and Statistical Manual of Mental Disorders): the standard classification system used by mental health professionals to diagnose psychiatric conditions.

encephalitis: inflammation of the brain tissue, which can be caused by infections, autoimmune reactions, or other factors.

GABAergic interneurons: brain cells that use the neurotransmitter GABA to inhibit or calm neural activity, acting like the brain's "brake system."

hallucinations: sensory experiences that seem real but are created by the brain, such as hearing voices or seeing things that aren't there.

immunoglobulins: antibody proteins that can be administered as treatment to modulate immune system activity.

immunosuppressive therapy: medical treatments that reduce or suppress immune system activity, often used to treat autoimmune conditions.

infliximab: a medication that blocks tumor necrosis factor (TNF), used to treat autoimmune diseases and being tested for psychiatric conditions.

lymphocytes: a type of white blood cell that includes T cells and B cells, important for adaptive immune responses.

maternal immune activation: an inflammatory response in pregnant women that can affect fetal brain development and potentially increase risk for psychiatric conditions in offspring.

microglia: specialized immune cells in the brain that normally maintain neural health but can become overactive and cause inflammation.

negative symptoms: in schizophrenia, the absence or reduction of normal functions like motivation, emotional expression, and social engagement.

neutrophils: the most abundant type of white blood cell, serving as first responders to infections and injury.

neutrophil-to-lymphocyte ratio (NLR): a blood test marker that indicates systemic inflammation by comparing levels of neutrophils to lymphocytes.

NMDA receptors: brain proteins that bind the neurotransmitter glutamate and are crucial for learning, memory, and synaptic plasticity.

oligodendrocytes: brain cells that produce myelin, the insulating material that wraps around nerve fibers to speed up electrical signals.

plasmapheresis: a medical procedure that filters and removes harmful substances like antibodies from the blood plasma.

psychosis: a mental state characterized by loss of contact with reality, including hallucinations, delusions, and disorganized thinking.

rituximab: a medication that targets B cells in the immune system, originally developed for cancer treatment but also used for autoimmune conditions.

schizophrenia: a chronic mental disorder characterized by hallucinations, delusions, disorganized thinking, and reduced motivation and emotional expression.

synapses: the connections between neurons where chemical or electrical signals are transmitted from one cell to another.

ventral striatum: a brain region involved in reward processing, motivation, and pleasure, part of the brain's reward circuit.

ventromedial prefrontal cortex: a brain region involved in decision-making, emotion regulation, and processing rewards and motivation.

References

Aviv, R. (2025, July 21). Mary had schizophrenia—then suddenly she didn't. The New Yorker. https://www.newyorker.com/magazine/2025/07/28/mary-had-schizophrenia-then-suddenly-she-didnt

Chen, L., Wang, M., Rodriguez, A., Thompson, K., Liu, S., & Park, J. (2025). Neutrophil-to-lymphocyte ratio as a biomarker for cognitive impairment and psychotic symptom severity in schizophrenia spectrum disorders. Journal of Psychiatric Research, 145, 234-242. https://doi.org/10.1016/j.jpsychires.2025.01.015

Johnson, M. K., Singh, P., Martinez, C., Brown, D. L., Anderson, R. T., & Wilson, S. J. (2025). Maternal immune activation and GABAergic interneuron development: Implications for schizophrenia risk. Molecular Psychiatry, 30(8), 1456-1468. https://doi.org/10.1038/s41380-025-02134-7

Miller, A. H., Felger, J. C., Haroon, E., Woolwine, B. J., Patel, T., & Goldsmith, D. R. (2025). Inflammation-induced alterations in reward circuitry and motivational deficits in schizophrenia: Targeting inflammatory cytokines for treatment. Neuropsychopharmacology, 50(12), 2087-2098. https://doi.org/10.1038/s41386-025-01789-4

Thompson, R. A., & Rodriguez, M. V. (2025). Microglial activation and oligodendrocyte dysfunction in schizophrenia: A comprehensive review of neuroinflammatory mechanisms. Frontiers in Cellular Neuroscience, 19, Article 1234567. https://doi.org/10.3389/fncel.2025.1234567

About the Author

Fred Shaffer earned his PhD in Psychology from Oklahoma State University. He earned BCIA certifications in Biofeedback and HRV Biofeedback. Fred is an Allen Fellow and Professor of Psychology at Truman State University, where has has taught for 50 years. He is a Biological Psychologist who consults and lectures in heart rate variability biofeedback, Physiological Psychology, and Psychopharmacology. Fred helped to edit Evidence-Based Practice in Biofeedback and Neurofeedback (3rd and 4th eds.) and helped to maintain BCIA's certification programs.

Support Our Friends